Mounjaro and Fertility UK: What You Need to Know

Mounjaro can improve fertility in women with obesity-related infertility or PCOS by reducing insulin resistance and restoring hormonal balance — but it must be stopped before trying to conceive. The clinical picture is nuanced: weight loss itself improves fertility, tirzepatide does this more effectively than most interventions, but the medication isn’t safe during pregnancy. This guide covers what the evidence shows for fertility, the right timing for stopping, and what to discuss with your GP or fertility specialist.

Related reading: GLP-1 Fertility and Pregnancy UK and Mounjaro and the Contraceptive Pill UK.

How Mounjaro affects fertility

The connection runs through two mechanisms:

1. Weight loss and hormonal restoration

Excess body fat produces oestrogen independently, disrupting the hormonal signalling required for regular ovulation. Women with BMI above 30 have significantly higher rates of anovulatory cycles (cycles where no egg is released), irregular periods, and difficulty conceiving. Even modest weight loss of 5–10% has been shown to restore ovulatory function in women with obesity-related infertility.

Mounjaro produces the most substantial weight loss of any currently available non-surgical intervention — average 15–22% body weight at 72 weeks. For women whose fertility difficulties are primarily driven by weight, this level of loss can fundamentally change their hormonal picture.

2. Insulin resistance reduction

As a dual GLP-1 and GIP receptor agonist, tirzepatide directly improves insulin sensitivity. High insulin levels suppress sex hormone binding globulin (SHBG), which in turn elevates free androgens — this is a central mechanism in PCOS-related infertility. Improving insulin sensitivity reduces androgens, raises SHBG, and supports more regular ovulation.

This means Mounjaro may improve fertility through two separate pathways simultaneously: weight reduction and direct insulin-sensitising effects, rather than just weight loss alone.

Mounjaro and PCOS

PCOS affects around 1 in 10 women of reproductive age in the UK and is the most common cause of female infertility. Its core drivers — insulin resistance, androgen excess, and disrupted ovulation — are directly addressed by GLP-1 treatment.

For women with PCOS on Mounjaro, reported changes include:

• More regular menstrual cycles as ovulation restores
• Reduced symptoms of androgen excess (acne, hirsutism)
• Improved metabolic markers (fasting glucose, insulin)
• Weight loss that reduces the cycle of insulin resistance driving further hormonal disruption

See GLP-1 for PCOS UK for more on this specifically.

The important practical point for PCOS: improved ovulation means improved fertility, which means the risk of unintended pregnancy increases on Mounjaro for women who previously had irregular cycles. Reliable contraception is essential. See Mounjaro and the Contraceptive Pill UK — oral contraceptives specifically may have reduced efficacy due to gastric emptying effects.

Is Mounjaro safe in pregnancy?

No. Tirzepatide is not recommended during pregnancy. Animal studies showed adverse effects on foetal development at doses relevant to human exposure. While there are no large human trials (for obvious ethical reasons), the precautionary principle applies firmly here.

The Mounjaro UK prescribing information is explicit: discontinue before trying to conceive, and do not use during pregnancy or breastfeeding.

There is no evidence suggesting tirzepatide causes birth defects in humans — the animal data involves much higher relative doses than humans take — but the absence of safety data means clinicians universally recommend stopping before attempting pregnancy.

When to stop Mounjaro before trying to conceive

The standard recommendation is to stop Mounjaro at least two months (eight weeks) before trying to conceive. This allows:

• The medication to fully clear from circulation (half-life approximately five days; fully cleared within four to five weeks)
• A buffer period to ensure stable weight and nutrition before conception
• Time to transition contraception if relevant

Some fertility specialists recommend a longer gap — three to six months — to allow weight to stabilise before conception, since rapid ongoing weight loss during early pregnancy is not ideal. Discuss the specific timing with both your prescriber and your fertility team.

Stop Mounjaro immediately if you become pregnant

If you become pregnant while on Mounjaro, stop immediately and contact your GP. Do not wait for your next prescriber review. Inform your midwife and obstetric team that you were taking tirzepatide and the approximate date of your last dose. This information goes into your pregnancy records and allows appropriate monitoring.

Most women who become pregnant while on Mounjaro go on to have normal pregnancies. The medication clears quickly. The key is stopping promptly on discovering the pregnancy rather than continuing.

Using Mounjaro to improve fertility before TTC

A deliberate approach some women take with medical guidance:

1. Start Mounjaro with the specific goal of reaching a weight associated with better fertility outcomes (often BMI below 30, or achieving 10–15% weight loss from starting weight)
2. Achieve target weight or meaningful weight loss
3. Allow weight to stabilise for 2–3 months
4. Stop Mounjaro at least two months before trying to conceive
5. Begin trying to conceive with improved hormonal balance and insulin sensitivity

This approach is used in NHS and private fertility contexts for women where weight is a primary barrier to conception. It requires coordinated planning between your prescriber, GP, and fertility team if you’re under one.

Male fertility considerations

Less studied, but worth noting. Obesity in men is associated with reduced testosterone, lower sperm quality, and erectile dysfunction. Weight loss on Mounjaro improves testosterone levels and may improve sperm parameters, though direct tirzepatide-specific data on male fertility is limited.

There is no specific recommendation for men to stop Mounjaro before their partner conceives — the concern is about foetal exposure, which applies to the pregnant person, not the male partner. That said, individual fertility specialists may have views on this for specific couples; it’s worth raising if you’re actively trying to conceive.

What to track during the fertility-focused phase

If you’re on Mounjaro with fertility as a goal, tracking nutrition carefully is particularly relevant:

• Folate — critical for neural tube development from before conception. Check your folate intake in Cronometer and start a folate/folic acid supplement (400mcg daily, or 5mg if advised by GP for higher risk) before trying to conceive.
• Iron — stores matter before pregnancy. Low ferritin pre-conception predicts anaemia in pregnancy.
• Vitamin D — supports hormonal function and early pregnancy development. UK recommendations suggest supplementation for most adults regardless.
• Overall calorie adequacy — active rapid weight loss during the month you conceive is not ideal. If you’re close to stopping Mounjaro to try to conceive, aim for weight maintenance rather than continued rapid loss in those final months.

NHS fertility treatment and Mounjaro

Most NHS IVF services have BMI thresholds for treatment eligibility (typically BMI under 30–35 depending on the CCG). For women who have been ineligible for NHS IVF due to BMI, Mounjaro-assisted weight loss may bring them within eligibility — this is a clinically meaningful and increasingly common pathway.

If this applies to you, confirm with your local fertility service what their current BMI threshold is, track your BMI trajectory on Mounjaro, and plan the stop date to give yourself adequate time at a lower weight before applying.

Frequently asked questions

Can Mounjaro help me get pregnant?

Indirectly, yes — by addressing the weight and insulin resistance that contribute to fertility difficulties, particularly in PCOS. But Mounjaro itself must be stopped before trying to conceive.

How long after stopping Mounjaro can I try to conceive?

The standard recommendation is at least two months after your last dose. Some specialists prefer three to six months to allow weight to stabilise. Discuss your specific situation with your GP or fertility team.

Will my fertility decrease again if I regain weight after stopping Mounjaro?

Possibly. The fertility benefits of Mounjaro are largely mediated by weight loss and insulin improvement. If weight is regained after stopping, some of these benefits may reduce. This is one reason stabilising weight before trying to conceive — rather than stopping mid-loss-phase — tends to produce better outcomes.

Is it safe to breastfeed on Mounjaro?

No. Mounjaro is not recommended during breastfeeding. Animal studies suggest tirzepatide is present in breast milk. Stop Mounjaro before delivery and do not restart until breastfeeding is complete or you’ve chosen not to breastfeed.

I got pregnant while on Mounjaro — what should I do?

Stop Mounjaro immediately. Contact your GP the same day. Inform your midwife at your booking appointment that you were taking tirzepatide. Seek reassurance — most accidental exposures in early pregnancy on GLP-1s have not resulted in adverse outcomes, but medical oversight is appropriate.

Medical disclaimer: fertility decisions are personal and complex. This guide is general information only. Always involve your GP, prescriber, and fertility specialist in planning around Mounjaro and conception.

Nutritional preparation for conception after Mounjaro

The two-month gap between stopping Mounjaro and trying to conceive is also an active nutritional preparation window. Weight loss periods can deplete stores of key nutrients required for early pregnancy:

Folate/folic acid: the most critical pre-conception nutrient. Neural tube development begins before most women know they’re pregnant. Standard UK guidance is 400mcg daily from at least one month before trying to conceive (5mg for higher-risk women). Check your current dietary folate in Cronometer and start a supplement if you haven’t already.

Iron: rapid weight loss plus reduced red meat intake on a GLP-1 can deplete iron stores significantly. Low ferritin pre-conception predicts anaemia in pregnancy. Ask your GP for a ferritin test in the months before you intend to stop Mounjaro.

Vitamin D: UK recommendations advise supplementation for most adults, year-round. Particularly relevant for fertility and early pregnancy development. 10mcg (400 IU) daily is the standard UK guidance; some fertility specialists recommend 25mcg.

Omega-3 (DHA specifically): essential for foetal brain development. Dietary DHA from oily fish (salmon, mackerel, sardines) 2–3 times weekly, or a pregnancy-appropriate omega-3 supplement. See Omega-3 UK.

Starting a good prenatal multivitamin in the months before stopping Mounjaro covers most of these bases systematically. Discuss with your GP what’s appropriate for your specific circumstances.